Synthesis and Bioactivity of New Finasteride Conjugate

June 2011 in “ Bioorganic & Medicinal Chemistry Letters ”

Zhao Shuang, Wu Jiazhen, Yang Li-juan, Li Zhuo, Yu Dahai, Li JinFeng, Yu Jing, Liang Yongtao, Wang En-si, Fang Xue-xun

Finasteride 5α-reductase benign prostate hyperplasia immune response Polimod Propecia

TLDR New Finasteride conjugate improves prostate treatment and vital signs in rats.

The study aimed to develop a new Finasteride conjugate for the treatment of benign prostate hyperplasia (BPH). The new compound showed better inhibition of 5α-reductase activity in vitro and improved outcomes in vivo in a rat model with BPH. The rats in the Finasteride conjugate group also showed better vital signs than those in the Finasteride group. The results suggest that the Finasteride conjugate may have other functions on animals than Finasteride, possibly with improved immune response or reduced toxicity. Further research is needed to investigate the immune modulation activity of the Finasteride conjugate and compare it with Polimod.

View this study on sciencedirect.com →

Discuss this study in the Community →

Cited in this study

3 / 3 results

research Anabolic Effects of Testosterone Are Preserved During Inhibition of 5α-Reductase

42 citations , August 2007 in “Endocrinology and metabolism/American journal of physiology: endocrinology and metabolism”

Testosterone can build muscle and bone without enlarging the prostate when a specific enzyme is blocked.

research Inhibitors of 5α-Reductase in the Treatment of Benign Prostatic Hyperplasia

52 citations , March 2006 in “Current pharmaceutical design”

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

research The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment Among Men with Benign Prostatic Hyperplasia

1054 citations , February 1998 in “The New England Journal of Medicine”

Finasteride reduces urinary issues and surgery need in men with enlarged prostates by over 50%.

2 / 2 results

research Finasteride Inhibits 5α-Reductase Activity in Human Dermal Fibroblasts: Prediction of Its Therapeutic Application in Androgen-Related Skin Diseases

3 citations , October 1995 in “International Journal of Dermatology”

Finasteride helps treat skin issues like acne and baldness by blocking testosterone conversion.

research Effect of Finasteride, a 5 Alpha-Reductase Inhibitor, on Serum Gonadotropins in Normal Men

30 citations , August 1992 in “The Journal of Clinical Endocrinology and Metabolism”

Finasteride doesn't affect hormone levels in normal men.